These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1758481)

  • 21. Children and clandestine drug laboratories: the unseen victims.
    Hawkrigg SL; Winterton PM
    Med J Aust; 2013 Dec; 199(11):739-41. PubMed ID: 24329626
    [No Abstract]   [Full Text] [Related]  

  • 22. Implementation of the Comprehensive Methamphetamine Control Act of 1996; regulation of pseudoephedrine, phenylpropanolamine, and combination ephedrine drug products and reports of certain transactions to nonregulated persons. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2002 Mar; 67(60):14853-62. PubMed ID: 11922057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implementation of the Methamphetamine Anti-Proliferation Act; thresholds for retailers and for distributors required to submit mail order reports; changes to mail order reporting requirements. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Oct; 68(194):57799-804. PubMed ID: 14535265
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methamphetamine and the changing face of child welfare: practice principles for child welfare workers.
    Connell-Carrick K
    Child Welfare; 2007; 86(3):125-44. PubMed ID: 17722684
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methamphetamine: putting the brakes on speed.
    Gettig JP; Grady SE; Nowosadzka I
    J Sch Nurs; 2006 Apr; 22(2):66-73. PubMed ID: 16563028
    [TBL] [Abstract][Full Text] [Related]  

  • 26. What are club drugs? Here's a quick look.
    AIDS Alert; 2002 Oct; 17(10):123. PubMed ID: 12400464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of US and Canadian precursor regulation on methamphetamine purity in the United States.
    Cunningham JK; Liu LM; Callaghan R
    Addiction; 2009 Mar; 104(3):441-53. PubMed ID: 19207353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Special surveillance list of chemicals, products, materials and equipment used in the clandestine production of controlled substances or listed chemicals. Drug Enforcement Administration (DEA), Justice. Final notice.
    Fed Regist; 1999 May; 64(92):25910-2. PubMed ID: 10558537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Control of red phosphorus, white phosphorus and hypophosphorous acid (and its salts) as list I chemicals; exclusions and waivers. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2003 Jun; 68(121):37411-4. PubMed ID: 12836650
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [MHLW's countermeasures for uncontrolled substance and future tasks].
    Yamamoto J
    Chudoku Kenkyu; 2004 Jul; 17(3):245-50. PubMed ID: 15495683
    [No Abstract]   [Full Text] [Related]  

  • 31. Restricting the sale of pseudoephedrine to prevent methamphetamine production.
    Colker AC
    NCSL Legisbrief; 2005 Feb; 13(7):1-2. PubMed ID: 15726724
    [No Abstract]   [Full Text] [Related]  

  • 32. Meth labs.
    Goss JF
    JEMS; 1998 Jan; 23(1):50-2, 54, 56 passim. PubMed ID: 10178102
    [No Abstract]   [Full Text] [Related]  

  • 33. The association of pseudoephedrine sales restrictions on emergency department urine drug screen results in Oklahoma.
    Brandenburg MA; Brown SJ; Arneson WL; Arneson DL
    J Okla State Med Assoc; 2007 Nov; 100(11):436-9. PubMed ID: 18183861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ADA applauds legislators for 'meth mouth' bills.
    J Okla Dent Assoc; 2010 Nov; 101(8):29. PubMed ID: 21197923
    [No Abstract]   [Full Text] [Related]  

  • 35. A dangerous business.
    Fuller K
    Occup Health Saf; 2005 Sep; 74(9):188, 190-1. PubMed ID: 16225016
    [No Abstract]   [Full Text] [Related]  

  • 36. Schedules of controlled substances: extension of temporary placement of methylone into schedule I of the Controlled Substances Act. Final order.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2012 Oct; 77(202):64032-3. PubMed ID: 23077760
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementation of the Methamphetamine Production Prevention Act of 2008. Final rule.
    Drug Enforcement Administration (DEA), Justice
    Fed Regist; 2011 Dec; 76(231):74696-9. PubMed ID: 22145189
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clandestine drug laboratories in Australia and the potential for harm.
    Caldicott DG; Pigou PE; Beattie R; Edwards JW
    Aust N Z J Public Health; 2005 Apr; 29(2):155-62. PubMed ID: 15915620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of methamphetamine precursor chemical legislation, a suppression policy, on the demand for drug treatment.
    Cunningham JK; Liu LM
    Soc Sci Med; 2008 Apr; 66(7):1463-73. PubMed ID: 18222587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacists on the front lines in the fight against meth. A 50-state comparison of the laws regulating the retail sale of pseudoephedrine.
    Rigdon BA
    J Leg Med; 2012 Apr; 33(2):253-83. PubMed ID: 22694096
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.